Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard A Smith

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
The Protein Journal|January 8, 2005
Factors affecting autocatalysis of botulinum A neurotoxin light chainS Ashraf Ahmed, Matthew L Ludivico, Leonard A Smith
Critical Reviews in Immunology|April 8, 2010
Mode of action of botulinum neurotoxins: current vaccination strategies and molecular immune recognitionK Roger Aoki, Leonard A Smith, M Zouhair Atassi
Disaster Medicine and Public Health Preparedness|April 5, 2008
Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalitiesZygmunt F Dembek, Leonard A Smith, Janice M Rusnak
Analytical Biochemistry|September 29, 2009
Rapid product analysis and increased sensitivity for quantitative determinations of botulinum neurotoxin proteolytic activityBenjamin Rowe, James J Schmidt, Leonard A Smith, et al.
IEEE Transactions on Bio-Medical Engineering|April 3, 2003
A dynamical model for generating synthetic electrocardiogram signalsPatrick E McSharry, Gari D Clifford, Lionel Tarassenko, et al.
Biotechnology Progress|April 2, 2005
Maximization of production of secreted recombinant proteins in Pichia pastoris fed-batch fermentationWenhui Zhang, Jayanta Sinha, Leonard A Smith, et al.
Journal of AOAC International|March 22, 2013
EL4 cell-based colorimetric toxin neutralization activity assays for determination of neutralizing anti-ricin antibodiesChanghong Y Lindsey, J Edward Brown, Nahid R Torabazar, et al.
Vaccine|December 19, 2020
Development of an o-pthalaldehyde (OPA) assay to measure protein content in Ricin Vaccine E. coli (RVEc™)Vicki A Montgomery, Changhong Y Lindsey, Leonard A Smith, et al.
Biochemical and Biophysical Research Communications|March 23, 2005
N-terminal helix reorients in recombinant C-fragment of Clostridium botulinum type BSeetharaman Jayaraman, Subramaniam Eswaramoorthy, S Ashraf Ahmed, et al.
Vaccine|May 20, 2009
Production of catalytically inactive BoNT/A1 holoprotein and comparison with BoNT/A1 subunit vaccines against toxin subtypes A1, A2, and A3Robert P Webb, Theresa J Smith, Patrick Wright, et al.
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
The Protein Journal|January 8, 2005
Factors affecting autocatalysis of botulinum A neurotoxin light chainS Ashraf Ahmed, Matthew L Ludivico, Leonard A Smith
Critical Reviews in Immunology|April 8, 2010
Mode of action of botulinum neurotoxins: current vaccination strategies and molecular immune recognitionK Roger Aoki, Leonard A Smith, M Zouhair Atassi
Disaster Medicine and Public Health Preparedness|April 5, 2008
Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalitiesZygmunt F Dembek, Leonard A Smith, Janice M Rusnak
Analytical Biochemistry|September 29, 2009
Rapid product analysis and increased sensitivity for quantitative determinations of botulinum neurotoxin proteolytic activityBenjamin Rowe, James J Schmidt, Leonard A Smith, et al.
IEEE Transactions on Bio-Medical Engineering|April 3, 2003
A dynamical model for generating synthetic electrocardiogram signalsPatrick E McSharry, Gari D Clifford, Lionel Tarassenko, et al.
Biotechnology Progress|April 2, 2005
Maximization of production of secreted recombinant proteins in Pichia pastoris fed-batch fermentationWenhui Zhang, Jayanta Sinha, Leonard A Smith, et al.
Journal of AOAC International|March 22, 2013
EL4 cell-based colorimetric toxin neutralization activity assays for determination of neutralizing anti-ricin antibodiesChanghong Y Lindsey, J Edward Brown, Nahid R Torabazar, et al.
Vaccine|December 19, 2020
Development of an o-pthalaldehyde (OPA) assay to measure protein content in Ricin Vaccine E. coli (RVEc™)Vicki A Montgomery, Changhong Y Lindsey, Leonard A Smith, et al.
Biochemical and Biophysical Research Communications|March 23, 2005
N-terminal helix reorients in recombinant C-fragment of Clostridium botulinum type BSeetharaman Jayaraman, Subramaniam Eswaramoorthy, S Ashraf Ahmed, et al.
Vaccine|May 20, 2009
Production of catalytically inactive BoNT/A1 holoprotein and comparison with BoNT/A1 subunit vaccines against toxin subtypes A1, A2, and A3Robert P Webb, Theresa J Smith, Patrick Wright, et al.
Pageof 9